Suppliers in Puerto Rico - Address, Contact

265 Medicare Suppliers found. Showing 261 - 265

Clinica Visual Villalba Medicare Supplier Location: 18 Calle Munoz Rivera, Villalba, Puerto Rico 00766 Phone: (787) 847-1234

Farmacia Villalba Durable Medical Equipment & Medical Supplies Location: Carr 149 Km 58 Hm 1, Villalba, Puerto Rico 00766 Phone: (787) 847-8600

Farmacia Feliciano 1 Durable Medical Equipment & Medical Supplies Location: Cristobal Colon #5, Yabucoa, Puerto Rico 00767 Phone: (787) 893-2280

Walgreens #929 Durable Medical Equipment & Medical Supplies Location: Carr. #3, Int. 901, Desvio Yabucoa, Yabucoa, Puerto Rico 00767 Phone: (787) 893-4410

Walgreens #323 Durable Medical Equipment & Medical Supplies Location: Centro Comercial Plaza Ii, Int. Carr. #2 Y Carr. #128, Yauco, Puerto Rico 00698 Phone: (787) 267-5727

News Archive

Research roundup: Reform's impact on health spending; Cultural/Racial differences in medicine; Swine flu lessons

The Impact Of Health Reform On Health Spending - This issue brief "projects the effect of national reform on total national health expenditures and the insurance premiums that American families would likely pay. We estimate that, on net, the combination of provisions in the new law will reduce health care spending by $590 billion over 2010-2019 and lower premiums by nearly $2,000 per family.

Can a new combination treatment prevent a secondary stroke in children with sickle cell anemia?

St. Jude Children's Research Hospital will lead a national Phase III clinical trial to investigate whether a new combination treatment can prevent a secondary stroke in children with sickle cell anemia (SCA) and eliminate the need for nightly injections with a drug that reduces iron overload in these patients.

Seattle Genetics completes enrollment of its pivotal clinical trial of brentuximab vedotin

Seattle Genetics, Inc. today announced that it has completed enrollment of its pivotal clinical trial of brentuximab vedotin (SGN-35) for relapsed and refractory Hodgkin lymphoma. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30 utilizing the company's proprietary ADC technology.

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.

TTUHSC professor receives 2020 Lupus Mechanisms and Targets Award

The Lupus Research Alliance recently named R. Bryan Sutton, Ph.D., a professor in the Department of Cell Physiology and Molecular Biophysics at the Texas Tech University Health Sciences Center, as a recipient of a 2020 Lupus Mechanisms and Targets Award.

Read more Medical News

› Verified 9 days ago

• «
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14(current)